Cheng-jiang Wei
Shanghai, 200011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.
Journal: NPJ digital medicine
Published: February 23, 2024
Unraveling intratumoral complexity in metastatic dermatofibrosarcoma protuberans through single-cell RNA sequencing analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: September 01, 2023
Long History of Multiple Painless Scalp Nodules in a Middle-aged Woman.
Journal: JAMA dermatology
Published: March 01, 2023
Laser treatment for Cafe-au-lait Macules: a systematic review and meta-analysis.
Journal: European journal of medical research
Published: November 09, 2022
Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1.
Journal: Signal transduction and targeted therapy
Published: September 15, 2022
Case Report: Differential diagnosis for tuberous sclerosis and neurofibromatosis type 1 diagnostic pitfall of aggressively enlarged right upper limb.
Journal: Frontiers in oncology
Published: July 30, 2022
Community-boosted neurofibromatosis research in China.
Journal: The Lancet. Neurology
Published: May 24, 2022
Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1.
Journal: Frontiers in neurology
Published: May 03, 2021
Clinical comparison of tenosynovial giant cell tumors, synovial chondromatosis, and synovial sarcoma: analysis and report of 53 cases.
Journal: Annals of translational medicine
Published: February 02, 2021
Combined Cyclin-Dependent Kinase Inhibition Overcomes MAPK/Extracellular Signal-Regulated Kinase Kinase Inhibitor Resistance in Plexiform Neurofibroma of Neurofibromatosis Type I.
Journal: The Journal of investigative dermatology
Published: January 18, 2021
Last Updated: 09/26/2026